
Axcella Health AXLA
Quarterly report 2023-Q2
added 08-03-2023
Axcella Health EBITDA per Share 2011-2026 | AXLA
Annual EBITDA per Share Axcella Health
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| -1.41 | -1.62 | -1.44 | -3.42 | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| -1.41 | -3.42 | -1.97 |
Quarterly EBITDA per Share Axcella Health
| 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | -0.06 | - | -0.32 | -0.39 | -0.44 | - | -0.38 | -0.4 | -0.38 | - | -0.31 | -0.44 | -0.62 | - | -0.71 | -0.9 | -2.27 | - | -1.55 | -1.88 | -1.71 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| -0.06 | -2.27 | -0.798 |
EBITDA per Share of other stocks in the Biotechnology industry
| Issuer | EBITDA per Share | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
MorphoSys AG
MOR
|
-15.2 | - | 2.43 % | $ 254 M | ||
|
Aligos Therapeutics
ALGS
|
-8.81 | $ 8.74 | 0.23 % | $ 86.4 M | ||
|
Allakos
ALLK
|
-2.19 | - | - | $ 28.6 M | ||
|
Alterity Therapeutics Limited
ATHE
|
-1.68 | $ 3.6 | -1.64 % | $ 8.66 B | ||
|
Aptinyx
APTX
|
-0.92 | - | -39.0 % | $ 4.57 M | ||
|
Aravive
ARAV
|
-1.92 | - | -13.39 % | $ 1.45 M | ||
|
I-Mab
IMAB
|
0.08 | - | - | $ 866 M | ||
|
Anavex Life Sciences Corp.
AVXL
|
-0.6 | $ 3.26 | 4.66 % | $ 278 M | ||
|
AlloVir
ALVR
|
-3.02 | - | 4.14 % | $ 49.1 M | ||
|
Applied Molecular Transport
AMTI
|
-3.2 | - | - | $ 10.1 M | ||
|
Alexion Pharmaceuticals, Inc.
ALXN
|
6.75 | - | - | $ 40.3 B | ||
|
Genfit SA
GNFT
|
-2.24 | - | 2.54 % | $ 160 B | ||
|
Biophytis SA
BPTS
|
-0.23 | - | -13.47 % | $ 169 M | ||
|
Brainstorm Cell Therapeutics
BCLI
|
-1.05 | - | -2.5 % | $ 5.88 M | ||
|
Applied Therapeutics
APLT
|
-0.77 | - | - | $ 8.42 M | ||
|
EyeGate Pharmaceuticals, Inc.
EYEG
|
2.22 | - | -1.52 % | $ 24.7 M | ||
|
BeiGene, Ltd.
BGNE
|
0.42 | - | 0.49 % | $ 251 B | ||
|
bluebird bio
BLUE
|
-1.97 | - | - | $ 546 M | ||
|
Midatech Pharma plc
MTP
|
-0.09 | - | -18.52 % | $ 27.3 M | ||
|
BioNTech SE
BNTX
|
62.6 | $ 97.5 | 0.82 % | $ 27.2 B | ||
|
Burford Capital Limited
BUR
|
1.11 | $ 4.7 | 4.44 % | $ 747 M | ||
|
Cabaletta Bio
CABA
|
-1.7 | $ 3.21 | 0.16 % | $ 323 M | ||
|
Amphastar Pharmaceuticals
AMPH
|
3.68 | $ 21.54 | 0.84 % | $ 1.01 B | ||
|
Checkpoint Therapeutics
CKPT
|
-1.42 | - | - | $ 169 M | ||
|
Институт стволовых клеток человека
ISKJ
|
-2.69 | - | - | - | ||
|
Adverum Biotechnologies
ADVM
|
-6.85 | - | - | $ 86.2 M | ||
|
Advaxis
ADXS
|
-5.96 | - | -9.65 % | $ 45.9 M | ||
|
Clearside Biomedical
CLSD
|
-0.4 | - | - | $ 25.3 M | ||
|
Aeterna Zentaris
AEZS
|
-0.08 | - | 5.93 % | $ 314 M | ||
|
AgeX Therapeutics
AGE
|
-2.35 | - | -10.17 % | $ 12.2 K | ||
|
Aeglea BioTherapeutics
AGLE
|
-6.7 | - | - | $ 1.01 B | ||
|
Akebia Therapeutics
AKBA
|
0.1 | $ 1.53 | 3.74 % | $ 393 M | ||
|
Applied Genetic Technologies Corporation
AGTC
|
-0.36 | - | - | $ 26.5 M | ||
|
Can-Fite BioPharma Ltd.
CANF
|
-6.03 | $ 3.03 | 3.77 % | $ 4.99 M | ||
|
Aquestive Therapeutics
AQST
|
-0.66 | $ 4.21 | 0.48 % | $ 450 M | ||
|
Arcutis Biotherapeutics
ARQT
|
-0.09 | $ 25.19 | 4.42 % | $ 3.21 B | ||
|
Chimerix
CMRX
|
-1.05 | - | - | $ 756 M | ||
|
Concert Pharmaceuticals
CNCE
|
-2.21 | - | - | $ 401 M | ||
|
AIkido Pharma
AIKI
|
-3.89 | - | 1.93 % | $ 17.4 M | ||
|
Celldex Therapeutics
CLDX
|
-4.28 | $ 33.26 | 2.04 % | $ 2.21 B | ||
|
Autolus Therapeutics plc
AUTL
|
-0.99 | $ 1.51 | 2.38 % | $ 402 M | ||
|
Aptose Biosciences
APTO
|
0.01 | - | -45.71 % | $ 1.2 M | ||
|
Cidara Therapeutics
CDTX
|
-27.7 | - | - | $ 1.41 B | ||
|
AVROBIO
AVRO
|
0.24 | - | 1083.1 % | $ 745 M | ||
|
CNS Pharmaceuticals
CNSP
|
-36 | $ 2.46 | -2.19 % | $ 1.09 M | ||
|
Ayala Pharmaceuticals
AYLA
|
-2.42 | - | - | $ 7.46 M | ||
|
AstraZeneca PLC
AZN
|
0.74 | - | - | $ 96.9 B | ||
|
Akero Therapeutics
AKRO
|
-4.25 | - | - | $ 3.67 B | ||
|
CTI BioPharma Corp.
CTIC
|
-0.68 | - | - | $ 1.2 B | ||
|
CureVac N.V.
CVAC
|
-2.22 | - | - | $ 867 M |